Quick Answer
Cell Source, Inc. reported R&D Expense of $1.94 million for fiscal year 2022.
Cell Source, Inc. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2022 | $1.94M | +52.2% |
| 2021 | $1.27M | +52.5% |
| 2020 | $834.9K | -66.0% |
| 2019 | $2.46M | +793.7% |
| 2018 | $274.9K | -56.9% |
| 2017 | $637.3K | +15.0% |
| 2016 | $554.2K | +41.0% |
| 2015 | $392.9K | -51.3% |
| 2014 | $806.2K | +129.3% |
| 2013 | $351.5K | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2022 | $468.0K | +4.8% | -15.7% |
| June 30, 2022 | $555.0K | +56.3% | +19.5% |
| March 31, 2022 | $464.5K | +97.0% | +4.0% |
| September 30, 2021 | $446.8K | +73.5% | +25.8% |
| June 30, 2021 | $355.1K | +122.0% | +50.6% |
| March 31, 2021 | $235.8K | -8.5% | -8.5% |
| September 30, 2020 | $257.5K | -77.8% | +61.0% |
| June 30, 2020 | $159.9K | -58.5% | -37.9% |
- Cell Source, Inc. showed an increase of +52.2% in R&D Expense compared to the prior fiscal year.
- Over the 2013–2022 period, Cell Source, Inc.’s r&d expense has grown by 451.4% (from $351.5 thousand to $1.94 million).
- The most recent figure is from Cell Source, Inc.’s fiscal year 2022 report (Form 10-K), filed with the SEC on August 8, 2023.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: